You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

neoantigen

Showing 26 - 50 of 213
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor Trial (Neoantigen mRNA Personalised Cancer SW1115C3)

Not yet recruiting
  • Solid Tumor
  • Neoantigen mRNA Personalised Cancer SW1115C3
  • (no location specified)
Feb 7, 2022

Pancreas Cancer, Pancreatic Cancer, Cancer of the Pancreas Trial in Saint Louis (biological, drug, procedure)

Recruiting
  • Pancreas Cancer
  • +2 more
  • Neoantigen Peptide Vaccine
  • +2 more
  • Baltimore, Maryland
  • +1 more
Mar 15, 2022

Gastric Cancer Trial in Beijing (neoantigen tumor vaccine with or without PD-1/L1)

Not yet recruiting
  • Gastric Cancer
  • neoantigen tumor vaccine with or without PD-1/L1
  • Beijing, China
    Department of GI Oncology, Peking University Cancer Hospital,
Jan 26, 2022

Biochemically Recurrent Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (biological, drug, other)

Recruiting
  • Biochemically Recurrent Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Durvalumab
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 26, 2023

Solid Tumor Trial in Beijing (XH001+ sintilimab)

Recruiting
  • Solid Tumor
  • XH001+ sintilimab
  • Beijing, Beijing, China
    PLA General Hospital
Jul 10, 2023

Glioblastoma Trial in Boston (radiation, biological, drug)

Recruiting
  • Glioblastoma
  • Radiation Therapy
  • +3 more
  • Boston, Massachusetts
  • +1 more
May 31, 2022

Kidney Cancer Trial in Boston (NeoVax, Ipilimumab)

Recruiting
  • Kidney Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 22, 2022

Pancreatic Cancer Trial in Shanghai (Adebrelimab, mRNA tumor vaccines)

Not yet recruiting
  • Pancreatic Cancer
  • Shanghai, Shanghai, China
    Department of Pancreatic Surgery, Fudan University Shanghai Canc
Dec 4, 2023

Advanced Solid Tumor Trial in Shanghai (Personalized neoantigen tumor vaccine)

Recruiting
  • Advanced Solid Tumor
  • Personalized neoantigen tumor vaccine
  • Shanghai, Shanghai, China
    Ruijin Hospital Shanghai Jiaotong University School of Medicine
Jun 24, 2023

Advanced Pancreatic Cancer Trial in Qionghai (Personalized neoantigen tumor vaccine)

Recruiting
  • Advanced Pancreatic Cancer
  • Personalized neoantigen tumor vaccine
  • Qionghai, Hainan, China
    Ruijin-Hainan Hospital Affiliated to Shanghai Jiao Tong Universi
Jun 14, 2023

Follicular Lymphoma Trial in Boston (Rituximab, Neo Vax, Pembrolizumab)

Recruiting
  • Follicular Lymphoma
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 14, 2022

Resectable Pancreatic Cancer Trial in Hangzhou (iNeo-Vac-P01, GM-CSF)

Recruiting
  • Resectable Pancreatic Cancer
  • iNeo-Vac-P01
  • GM-CSF
  • Hangzhou, Zhejiang, China
    Zhejiang Provincial People's Hospital
Nov 15, 2021

Gastric Cancer, Esophageal Cancer, Liver Cancer Trial in Beijing (neoantigen tumor vaccine with or without PD-1/L1)

Recruiting
  • Gastric Cancer
  • +2 more
  • neoantigen tumor vaccine with or without PD-1/L1
  • Beijing, Beijing, China
    PLA General Hospital
Jan 27, 2022

Melanoma Trial (V940, Pembrolizumab, Placebo)

Not yet recruiting
  • Melanoma
  • V940
  • +2 more
  • (no location specified)
Jul 12, 2023

HLA Typing and Tumor Neoantigen Identification forPhase I/II

Recruiting
  • Ovarian Cancer
  • +5 more
    • Houston, Texas
      MD Anderson Cancer Center
    Jul 27, 2022

    Carcinoma, Melanoma, Bladder Cancer Trial in Chengdu (Tumor antigen-sensitized DC vaccine and their sensitized T cells

    Not yet recruiting
    • Carcinoma
    • +3 more
    • Tumor antigen-sensitized DC vaccine and their sensitized T cells subcutaneous administration
    • Chengdu, Sichuan, China
      West China Hospital
    Feb 10, 2022

    Advanced Malignant Solid Tumor Trial in Hangzhou (iNeo-Vac-P01, GM-CSF)

    Active, not recruiting
    • Advanced Malignant Solid Tumor
    • iNeo-Vac-P01
    • GM-CSF
    • Hangzhou, Zhejiang, China
      Sir Run Run Shaw Hospital
    Nov 15, 2021

    Pancreatic Cancer, Pancreatic Carcinoma Trial in Hangzhou (iNeo-Vac-P01, GM-CSF)

    Completed
    • Pancreatic Cancer
    • Pancreatic Carcinoma
    • iNeo-Vac-P01
    • GM-CSF
    • Hangzhou, Zhejiang, China
      Zhejiang Provincial People's Hospital
    Nov 15, 2021

    HCC Trial in Baltimore, New York, Auckland (biological, drug, device)

    Recruiting
    • HCC
    • GNOS-PV02
    • +3 more
    • Baltimore, Maryland
    • +2 more
    Apr 26, 2022

    Advanced Solid Tumor Trial in Taoyuan (Neoantigen-expanded cell therapy.)

    Recruiting
    • Advanced Solid Tumor
    • Neoantigen-expanded cell therapy.
    • Taoyuan, Taiwan
      Chang Gung Memorial Hospital, Linkou
    Aug 18, 2021

    Posto Perative Hepatocellular Carcinoma Trial (Neoantigen mRNA Personalised Cancer vaccine in combination with Stintilimab I

    Not yet recruiting
    • Posto Perative Hepatocellular Carcinoma
    • Neoantigen mRNA Personalised Cancer vaccine in combination with Stintilimab I njection
    • (no location specified)
    Feb 27, 2023

    Glioblastoma Multiforme of Brain Trial (biological, procedure, radiation, drug)

    Not yet recruiting
    • Glioblastoma Multiforme of Brain
    • TVI-Brain-1
    • +3 more
    • (no location specified)
    Jan 13, 2023

    Pancreatic Cancer, Pancreas Cancer, Cancer of the Pancreas Trial in Baltimore, Saint Louis (biological, device, procedure)

    Active, not recruiting
    • Pancreatic Cancer
    • +2 more
    • Personalized neoantigen DNA vaccine
    • +2 more
    • Baltimore, Maryland
    • +1 more
    Sep 15, 2021

    Advanced Hepatocellular Carcinoma Trial in Beijing (Neoantigen vaccine, I.M injection)

    Recruiting
    • Advanced Hepatocellular Carcinoma
    • Neoantigen vaccine, I.M injection
    • Beijing, Beijing, China
      Peking Union Medical College Hospital, Chinese Academy of Medica
    Jul 31, 2023

    Advanced Lung Carcinoma Trial in Beijing (LK101 injection (personlized neoantigen pulsed DC vaccine ), Pembrolizumab,

    Recruiting
    • Advanced Lung Carcinoma
    • LK101 injection (personlized neoantigen pulsed DC vaccine )
    • +2 more
    • Beijing, Beijing, China
      Cancer hospital Chinese Academy of Medical Sciences
    May 23, 2023